Table 2 Serum Uric Acid Levels on admission in Relation to Demographics and Risk Factors in the population subgroups
From: Serum uri acid: neuroprotection in thrombolysis. The Bergen NORSTROKE study
SUA at admission, μmol/L (± SD) | ||||
|---|---|---|---|---|
rt-PA | Non rt-PA | Late | ||
n = 186 | n = 261 | n = 689 | p | |
Overall | 361 (± 97) | 348 (± 93) | 345 (± 104) | 0.03 |
Age | ||||
(> 65) | 367 (± 101) | 358 (± 90) | 357 (± 113) | 0.6 |
(≤ 65) | 352 (± 92) | 330 (± 95) | 324 (± 82) | 0.01 |
p* | 0.1 | 0.01 | 0.0001 | |
Female | 331 (± 102) | 310 (± 89) | 325 (± 111) | 0.3 |
Male | 378 (± 90) | 377 (± 85) | 361 (± 55.9) | 0.17 |
p* | 0.0007 | 0.0001 | 0.0001 | |
NIHSS day 0 | ||||
< 8 | 349 (± 86) | 347 (± 91) | 341 (± 96) | 0.6 |
8-14 | 359 (± 107) | 351 (± 108) | 356 (± 109) | 0.9 |
> 14 | 375 (± 103) | 355 (± 93) | 362 (± 137) | 0.7 |
p* | 0.2 | 0.9 | 0.1 | |
Hypertension | ||||
Yes | 396 (± 92) | 364 (± 94) | 365 (± 105) | 0.003 |
No | 327 (± 90) | 334 (± 88) | 321 (± 96) | 0.3 |
p* | 0.0001 | 0.005 | 0.0001 | |
Diabetes | ||||
Yes | 372 (± 109) | 361 (± 88) | 361 (± 113) | 0.3 |
No | 360 (± 96) | 347 (± 93) | 341 (± 101) | 0.03 |
p* | 0.3 | 0.2 | 0.03 | |